Frequent somatic mutations of KMT 2D ( MLL 2 ) and CARD 11 genes in primary cold agglutinin disease-Reference-Cited by-同舟云学术

Frequent somatic mutations of KMT 2D ( MLL 2 ) and CARD 11 genes in primary cold agglutinin disease

Published:2017-12-19 Issue:5 Volume:183 Page:838-842
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Małecka Agnieszka¹²^ORCID,Trøen Gunhild¹,Tierens Anne³,Østlie Ingunn¹,Małecki Jędrzej⁴,Randen Ulla¹,Wang Junbai¹,Berentsen Sigbjørn⁵,Tjønnfjord Geir E.⁶,Delabie Jan M. A.³⁷

Affiliation:

1. Department of Pathology Oslo University HospitalOslo Norway

2. Faculty of Medicine University of Oslo Oslo Norway

3. Laboratory Medicine Program University Health Network and University of Toronto Toronto ON Canada

4. Department of Biosciences University of Oslo OsloNorway

5. Department of Research and Innovation Haugesund Hospital Helse Fonna HaugesundNorway

6. Department of Haematology Oslo University Hospital and Institute of Clinical Medicine University of Oslo Oslo Norway

7. Center for Cancer Biomedicine University of Oslo Oslo Norway

Funder

Helse Sør-Øst RHF

Kreftforeningen

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15063

Reference10 articles.

1. Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia

2. Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies

3. Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

4. MLL2mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study

5. Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms;Expert Review of Hematology;2024-06-28

2. Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy;Current Oncology Reports;2024-06-14

3. New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications;International Journal of Hematology;2024-05-28

4. What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?;Journal of Hematopathology;2024-04-29

5. Плазмоклеточные опухоли в гематологических классификациях 2022 г.: WHO-HAEM5 (ВОЗ, 5-й пересмотр) и ICC (Международная консенсусная классификация). Взгляд клинициста;Clinical Oncohematology;2024-04-01